Disclosures for "Midazolam Versus Ketamine as the First-line Continuous Infusion for Status Epilepticus in Children with Congenital Heart Disease"
-
Mr. Javadian has nothing to disclose.
-
Ms. Keenan has nothing to disclose.
-
Ms. Liu has nothing to disclose.
-
Ms. Voleti has nothing to disclose.
-
Ms. Conley has nothing to disclose.
-
Mrs. Staso has nothing to disclose.
-
Dr. Horvat has nothing to disclose.
-
The institution of Dr. Schlatterer has received research support from Van Metre Foundation.
-
Dr. Sansevere has nothing to disclose.
-
The institution of Dr. Harrar has received research support from NIH. Dr. Harrar has received publishing royalties from a publication relating to health care.